Who should be prioritised for COVID-19 vaccination?

被引:53
|
作者
Russell, Fiona M. [1 ,2 ]
Greenwood, Brian [3 ]
机构
[1] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[2] Murdoch Childrens Res Inst, Asia Pacific Hlth Res, Melbourne, Vic, Australia
[3] London Sch Hyg & Trop Med, Dept Dis Control, London, England
基金
英国医学研究理事会;
关键词
COVID-19; vaccines; high-risk; epidemiology; transmission; vaccine development; clinical trials; WOMEN;
D O I
10.1080/21645515.2020.1827882
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine to be available within 6 months. So who should be prioritized for vaccination when in the first instance, there will be insufficient supply to meet demand? There is no doubt that health-care workers in all settings should be vaccinated first, but who comes next will be a complex decision based on local epidemiology, societal values, and the ability of the vaccines to prevent both severe disease and to reduce transmission thereby eliciting herd protection. The decision on who to vaccinate should be equitable, highly contextualized, and based on the property of each vaccine. In some settings, the elderly may be prioritized, in others, it may be the population most likely to get infected and responsible for community spread. To support decision-making on who to be prioritized for vaccination requires urgent additional research on the epidemiology of COVID-19; preexisting immunity and who is responsible for transmission in a variety of settings; the safety, immunogenicity, and efficacy of COVID-19 vaccines in children and pregnant women; and determining whether COVID-19 vaccines prevent asymptomatic infection and transmission.
引用
收藏
页码:1317 / 1321
页数:5
相关论文
共 50 条
  • [21] Vaccination against COVID-19 and pregnancy
    Lorena Macchia-de Sanchez, Carla
    Tatiana Villalba-Vizcaino, Vivian
    DUAZARY, 2021, 18 (03) : 309 - 320
  • [22] Considerations for COVID-19 vaccination in pregnancy
    Zamparini, J.
    Murray, L.
    Saggers, R. T.
    Wise, A. J.
    Lombaard, H.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2021, 111 (06): : 544 - 549
  • [23] COVID-19 vaccination and liver disease
    Ozaka, Sotaro
    Kobayashi, Takashi
    Mizukami, Kazuhiro
    Murakami, Kazunari
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (48) : 6791 - 6810
  • [24] Myocarditis Following COVID-19 Vaccination
    Marschner, Constantin A.
    Shaw, Kirsten E.
    Tijmes, Felipe Sanchez
    Fronza, Matteo
    Khullar, Sharmila
    Seidman, Michael A.
    Thavendiranathan, Paaladinesh
    Udell, Jacob A.
    Wald, Rachel M.
    Hanneman, Kate
    HEART FAILURE CLINICS, 2023, 19 (02) : 251 - 264
  • [25] Myocarditis Following COVID-19 Vaccination
    Marschner, Constantin A.
    Shaw, Kirsten E.
    Tijmes, Felipe Sanchez
    Fronza, Matteo
    Khullar, Sharmila
    Seidman, Michael A.
    Thavendiranathan, Paaladinesh
    Udell, Jacob A.
    Wald, Rachel M.
    Hanneman, Kate
    CARDIOLOGY CLINICS, 2022, 40 (03) : 375 - 388
  • [26] Audiovestibular and vaccination complications of COVID-19
    Gabr, Takwa
    Kotait, Mona
    Moaty, Asmaa Salah
    EGYPTIAN JOURNAL OF OTOLARYNGOLOGY, 2022, 38 (01)
  • [27] An Update on COVID-19 Vaccination and Pregnancy
    Julia-Burches, Cristina
    Martinez-Varea, Alicia
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [28] Vaccination in the context of the COVID-19 pandemic
    Diaz-Badillo, Alvaro
    Garibay-Nieto, Guadalupe N.
    Navas-Figueroa, Ana L.
    Perales-Torres, Adriana L.
    Concepcion Morales-Gomez, Maria
    Lopez-Alvarenga, Juan C.
    CIRUGIA Y CIRUJANOS, 2021, 89 (06): : 836 - 843
  • [29] Myocarditis Associated with COVID-19 Vaccination
    Florek, Kamila
    Sokolski, Mateusz
    VACCINES, 2024, 12 (10)
  • [30] COVID-19 Vaccination and Healthcare Demand
    Betti, Matthew I.
    Abouleish, Amira Hassan
    Spofford, Victoria
    Peddigrew, Cory
    Diener, Alan
    Heffernan, Jane M.
    BULLETIN OF MATHEMATICAL BIOLOGY, 2023, 85 (05)